Size-selective extraction of peptides from urine for mass spectrometric analysis.

chain reaction. Eur J Haematol 2001;67:302–8. 12. Visani G, Buonamici S, Malagola M, Isidori A, Piccaluga PP, Martinelli G, et al. Pulsed ATRA as single therapy restores long-term remission in PMLRAR -positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study. Leukemia 2001;15:1696– 700. 13. Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S, et al. Quantitative real-time RT-PCR analysis of PML-RARa mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood 2003;101:2521–8. 14. Gabert J, Beillard E, Van Der Velden VHJ, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of “real-time” quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia—A Europe Against Cancer Program. Leukemia 2003;17:2318–57. 15. Gabert J. RQ-PCR for early diagnosis of relapse risk in leukemia (Europe Against Cancer Program). http://ifrjr.nord.univ-mrs.fr/mrd_leukemia (accessed March 2002). 16. Kreuzer KA, Lass U, Bohn A, Landt O, Schmidt CHA. LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res 1999;59: 3171–4. 17. Barragan E, Bolufer P, Moreno I, Martin G, Nomdedeu J, Brunet S, et al. Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes. Leuk Lymphoma 2001;42:747–56.